Gruss Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Gruss Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-156,383	Closed	-$1.44M	–	74
2016 Q1	$1.44M	Hold	156,383	–	–	0.44%	42
2015 Q4	$1.97M	Hold	156,383	–	–	0.29%	72
2015 Q3	$1.89M	Hold	156,383	–	–	0.16%	74
2015 Q2	$2.72M	Hold	156,383	–	–	0.25%	58
2015 Q1	$2.27M	Buy	156,383 +2,883	+2%	+$31.5K	0.27%	59
2014 Q4	$1.29M	Buy	153,500 +17,200	+13%	+$157K	0.12%	82
2014 Q3	$1.51M	Buy	136,300 +82,975	+156%	+$1.05M	0.15%	62
2014 Q2	$976K	Buy	+53,325	New	+$694K	0.1%	65

Other funds holding AVEO

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return